Literature DB >> 1433379

Distribution of iodine into blood components of the Sprague-Dawley rat differs with the chemical form administered.

K D Thrall1, R J Bull, R L Sauer.   

Abstract

It has been reported previously that radioactivity derived from iodine distributes differently in the Sprague-Dawley rat depending on the chemical form administered (Thrall and Bull, 1990). In the present communication we report the differential distribution of radioactivity derived from iodine (I2) and iodide (I-) into blood components. Twice as much radioiodine is in the form of I- in the plasma of animals treated with 125I- compared to 125I2-treated rats. No I2 could be detected in the plasma. With an increase in dose, increasing amounts of radioactivity derived from 125I2-treated animals distribute to whole blood compared to equivalent doses of 125I-, reaching a maxima at a dose of 15.8 mumol I/kg body weight. Most of the radioactivity derived from I2 associates with serum proteins and lipids, in particular with albumin and cholesteryl iodide. These data indicate a differential distribution of radioactivity depending on whether it is administered as iodide or iodine. This is inconsistent with the commonly held view that iodine (I2) is reduced to iodide (I-) before it is absorbed systemically from the gastrointestinal tract.

Entities:  

Keywords:  NASA Discipline Environmental Health; Non-NASA Center

Mesh:

Substances:

Year:  1992        PMID: 1433379     DOI: 10.1080/15287399209531682

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  2 in total

1.  Different tissue responses for iodine and iodide in rat thyroid and mammary glands.

Authors:  B A Eskin; C E Grotkowski; C P Connolly; W R Ghent
Journal:  Biol Trace Elem Res       Date:  1995-07       Impact factor: 3.738

2.  Molecular iodine is not responsible for cytotoxicity in iodophors.

Authors:  C Freeman; E Duan; J Kessler
Journal:  J Hosp Infect       Date:  2022-02-04       Impact factor: 8.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.